PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   


Catalogue
Number
Product Order number / Unit

99381 PSMA I&T
Please inquire for customized filling and bulk quantities.

 
Precursor for radiometal-labelled PSMA I&T
PSMA: prostate-specific membrane antigen
Molar Mass:1498.37
C63H92IN11O23
[2192281-54-0] (net peptide)
Colourless to off-white solid packaged in plastic vials
Purity: > 95 %
Certificates:
CoA; MS (identity); HPLC (purity)
Sequence:
Glu-CO-Lys[(Sub)DLys-DPhe-DTyr(3I)-DOTAGA] trifluoroacetate
Literature:
Baum R.P. et al. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. J. Nucl. Med. 2016, 57, 1006-1013.
Eiber M. et al. Systemic Radioligand Therapy with 177Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. J. Nucl. Med., 2016, 57(supplement 2): p. 61-61.
Schottelius M. et al. [111In] PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015, 5, 68.
date of product catalogue issue: 27 February 2019

 
 
 

  PDF file       product list       home page       search       email       legal notice